NEWS
- Antibody-Drug Conjugates With Dual Payloads Against Heterogeneous Tumors
- Future Prospects of mRNA Therapeutics
- Design Elements And Design Criteria For ADC Drugs
- FDA Approves SYFOVRE™ – First Treatment for Geographic Atrophy
- Geographic Atrophy Treatments Under Investigation
- Complement Inhibitors as Therapeutic Agents
- Targeted Protein Degradation (TPD) Based On Nucleic Acid
- Overview New Therapeutic Drugs For Solid Tumors
- Visit Us at CPHI North America 2023, Booth #322
- Visit Us at PEGS Boston Summit 2023, Booth #212